The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The man who hopes to be President Donald Trump’s health secretary repeatedly asked to see “data” or “science” showing ...
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...